Related Experiment Video
Updated: Dec 19, 2025

07:39
How to Obtain Reliable Visual Event-related Potentials in Newborns
Published on: October 24, 2019
6.7K
Flash VEP in clinically stable pre-term and full-term infants
Anish Kharal1, Safal Khanal2, Jyoti Baba Shrestha1
1B.P. Koirala Lions Centre for Ophthalmic Studies, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal.
Documenta Ophthalmologica. Advances in Ophthalmology
|June 8, 2020
Summary
Pre-term infants show delayed visual development, with abnormal flash visual evoked potentials (VEPs) including slower P2 peak times and reduced P2 amplitudes compared to full-term infants.
Area of Science:
- Ophthalmology
- Neuroscience
- Developmental Pediatrics
Background:
- Preterm infants face risks for abnormal visual development.
- Visual pathway function can be subtly or severely affected.
- Early identification of visual pathway dysfunction is crucial.
Purpose of the Study:
- To compare flash visual evoked potentials (VEPs) in clinically stable preterm and full-term infants.
- To assess visual pathway maturation at 6 months corrected age.
- To investigate the relationship between VEPs and perinatal factors like gestational age and birth weight.
Main Methods:
- Flash VEPs were recorded in 25 preterm and 25 full-term infants at 6 months corrected age.
- Monocular VEPs were analyzed for P2 component amplitude and peak time.
- Regression analyses explored associations with gestational age (GA) and birth weight (BW).
Main Results:
- Preterm infants exhibited significantly delayed P2 peak times (10.88 ms difference, p=0.005).
- Preterm infants showed significantly reduced P2 amplitudes (2.36 µV difference, p=0.003).
- Gestational age was negatively related to P2 peak time (p=0.003), but neither GA nor BW related to P2 amplitude.
Conclusions:
- Clinically stable preterm infants demonstrate abnormal flash VEPs at 6 months corrected age.
- Delayed P2 peak time and reduced P2 amplitude suggest visual pathway dysfunction.
- These findings highlight the importance of monitoring visual development in preterm populations.

